Pharmafile Logo

Webinar: The patient journey: Time to look beyond the physician?

March 31, 2015 | Patient journey, webinar 

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

However a recent study demonstrated that physicians spend as little as 49 seconds in dealing with a new treatment initiation with their patients.

So it is no surprise that more and more pharma marketers are steadily looking beyond the physician in order to improve patient engagement.

Pharma companies are increasingly looking at “beyond the pill” strategies in order to gain greater patient engagement and to differentiate themselves in a crowded market. And so now more than ever, the researcher needs to ensure that they have a full understanding of the patient journey in order to sufficiently support their services strategy.

In this webinar Director Katrina Johnson and Associate Director Kate Hanson explore the ways that patient journey research can aid development of an effective “beyond the pill” strategy, leading to greater patient engagement and improved treatment outcomes. 

Gain answers to your key questions:

  • Learn how to overcome pitfalls associated in marketing to a non-DTC market
  • Identify the opportunities and challenges along the journey that affect patient engagement
  • Gain a deeper understanding of how the patient journey can provide pharma with a point of differentiation in a crowded market

To view this webinar please visit http://bit.ly/1y8lj3Y

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Full speed ahead: Unlock the full potential of your brand tracking

Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI...

Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST

PMRC New Jersey round up 2018

Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey

Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis

You can probably remember at least one of your friends in school who was always scratching and suffered from red, scaly skin rashes, perhaps on their elbows or backs of...

Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean

In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean

How we applied user-led design thinking in the ER setting to improve patient care

The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

Research conducted by Research Partnership published in leading medical journal

Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

Watch the webcast: http://bit.ly/2oTpzFjA shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories,...